Form 4 holding
Director, 10%+ Owner
Corvus Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 8,609,091
- Estimated value
- $66,290,000
- Report date
- 28 Jan 2026
- Price
- $7.70
- Ownership
- Indirect
Peter A. Thompson - Director, 10%+ Owner at Corvus Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- Director, 10%+ Owner
- Issuer ticker
- CRVS on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Peter A. Thompson since 05 Sep 2025
Reported holdings for Peter A. Thompson in Corvus Pharmaceuticals, Inc.
Form 4 holding
Director, 10%+ Owner
Corvus Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 210,000
- Estimated value
- $445,200
- Report date
- 28 Jan 2026
- Price
- $2.12
- Ownership
- Direct
Form 4 holding
Director, 10%+ Owner
Corvus Pharmaceuticals, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 15,000
- Estimated value
- Report date
- 11 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Corvus Pharmaceuticals, Inc.
- Security class
- Common Warrants (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 27 Jun 2025
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Peter A. Thompson in Corvus Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.